RxNorm 2641884 NDC Crossover
FLUCELVAX Quadrivalent 2023-2024 vaccine Injectable Suspension
Related NDC Codes to RxNorm Concept 2641884
The following NDC codes crossover to the RxNorm Concept 2641884. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
|---|---|---|---|---|---|---|---|
| 70461-323 | Flucelvax Quadrivalent | Influenza A Virus A/georgia/12/2022 Cvr-167 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza A Virus A/darwin/11/2021 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated),influenza B Virus B/singapore/wuh4618/2021 Antigen (mdck Cell Derived, Propiolactone Inactivated),influenza B Virus B/singapore/inftt-16-0610/2016 Antigen (mdck Cell Derived, Propiolactone Inactivated) | Injection, Suspension | Intramuscular | Seqirus Inc. | ACTIVE | |
| 70461-423 | Flucelvax Quadrivalent | Influenza A Virus A/georgia/12/2022 Crv-167 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza A Virus A/darwin/11/2021 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated),influenza B Virus B/singapore/wuh4618/2021 Antigen (mdck Cell Derived, Ropiolactone Inactivated),influenza B Virus B/singapore/inftt-16-0610/2016 Antigen (mdck Cell Derived, Propiolactone Inactivated) | Injection, Suspension | Intramuscular | Seqirus Inc. | ACTIVE |